January 4, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: | Vanessa Robertson | |||
Laura Crotty | ||||
Kevin Vaughn | ||||
Suzanne Hayes | ||||
Re: | Cullinan Management, Inc. (the Company) | |||
Registration Statement on Form S-1 | ||||
File No. 333-251512 |
Ladies and Gentleman:
In connection with the above-referenced Registration Statement, we wish to advise you that between January 4, 2021 and the date hereof we effected the distribution of approximately 700 copies of the Companys Preliminary Prospectus dated January 4, 2021 to prospective underwriters, institutional investors, prospective dealers, brokers, individuals, rating agencies and others.
We will comply and have been informed by the other participating underwriters that they will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
As Representatives of the several underwriters, we hereby join in the request of the Company that the effectiveness of the above-referenced Registration Statement, as amended, be accelerated to 5:15 p.m., Eastern Time, on January 6, 2021, or as soon thereafter as practicable.
[Signatures follow]
Very truly yours, | ||
MORGAN STANLEY & CO. LLC | ||
SVB LEERINK LLC | ||
EVERCORE GROUP LLC | ||
As Representatives of the several Underwriters | ||
MORGAN STANLEY & CO. LLC | ||
By: |
/s/ Kalli Dircks | |
Name: |
Kalli Dircks | |
Title: |
Executive Director | |
SVB LEERINK LLC | ||
By: |
/s/ Daniel B. Dubin | |
Name: |
Daniel B. Dubin, M.D. | |
Title: |
Vice Chairman, Head of Biopharma Investment Banking | |
EVERCORE GROUP LLC | ||
By: |
/s/ Maren Winnick | |
Name: |
Maren Winnick | |
Title: |
Senior Managing Director |